Biotech Values

[DewDiligence]

CELG inks drug-development collaboration in UC and Crohn’s disease—including a buyout option—with (private) Inception IBD Inc:

http://finance.yahoo.com/news/inception-celgene-enter-strategic-collaboration-130000288.html

Under terms of the agreement, Inception IBD is eligible to receive up to US$40 million in cash payments during the course of the collaboration, which enables Inception IBD to advance small molecule therapeutics from preclinical discovery to late preclinical development. The collaboration allows Inception IBD to significantly expand current drug discovery efforts, while Celgene will have a right to acquire the company upon conclusion of the collaboration.